Eargo, Inc.
EARDelisted Feb 16, 2024- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001719395
Eargo, Inc. was delisted on Feb 16, 2024; its insiders filed their last Form 4 on Feb 20, 2024; 23 institutions reported holding it in 13F filings for Q4 2023, worth $44.2M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Eargo, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −5 vs. Q1 2023
- Shares held
- 16.7M
- −112.8K (−0.7%) vs. Q1 2023
- Total value
- $82.4M
- +$3.65M (+4.6%) vs. Q1 2023
- New holders
- 2
- 5 more added
- Sold out
- 7
- 5 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 23 | $44.2M |
| Q3 2023 | 20 | $36.0M |
| Q2 2023 | 19 | $82.4M |
| Q1 2023 | 24 | $78.7M |
| Q4 2022 | 42 | $195.9M |
| Q3 2022 | 48 | $13.0M |
| Q2 2022 | 61 | $11.2M |
| Q1 2022 | 81 | $111.8M |
| Q4 2021 | 87 | $104.6M |
| Q3 2021 | 82 | $144.3M |
| Q2 2021 | 114 | $1.21B |
| Q1 2021 | 80 | $919.8M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Eargo, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Signaturefd, LLC | 53 | $261 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 463 | $2.28K | 0.00% | +463 | New |
| Group One Trading, L.P. | 515 | $2.54K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 933 | $5.00K | 0.00% | +681+270.2% | Added |
| Wells Fargo & Company | 1,037 | $5.11K | 0.00% | +1+0.1% | Added |
| Atlas Capital Advisors LLC | 1,223 | $6.03K | 0.00% | 00.0% | Unchanged |
| Byrne Asset Management LLC | 4,000 | $20.0K | 0.01% | +4,000 | New |
| Morgan Stanley | 5,277 | $26.0K | 0.00% | −137−2.5% | Reduced |
| CSS LLC | 8,656 | $42.7K | 0.00% | +250+3.0% | Added |
| Bank of America Corp | 11,844 | $58.4K | 0.00% | +51+0.4% | Added |
| Millennium Management LLC | 18,813 | $92.7K | 0.00% | −17,277−47.9% | Reduced |
| Renaissance Technologies LLC | 46,480 | $229.0K | 0.00% | −2,700−5.5% | Reduced |
| Geode Capital Management, LLC | 51,685 | $254.8K | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 54,002 | $266.2K | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 85,290 | $420.5K | 0.00% | +15,766+22.7% | Added |
| Nan Fung Group Holdings Ltd | 147,904 | $729.2K | 0.47% | 00.0% | Unchanged |
| NEA Management Company, LLC | 207,886 | $1.02M | 0.08% | −18,114−8.0% | Reduced |
| BlackRock Inc. | 242,883 | $1.20M | 0.00% | −50,966−17.3% | Reduced |
| Patient Square Capital LP | 15,821,299 | $78.0M | 37.97% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −25,057−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −19,354−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −147−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Baillie Gifford & Co | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −79−100.0% | Sold out |